查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1971984

寵物基因檢測套組市場：依寵物種類、檢測類型、通路、技術及最終用戶分類－2026年至2032年全球預測

Pet Genetic Test Kits Market by Pet Type, Test Type, Distribution Channel, Technology, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，寵物基因檢測套組市場價值將達到 4.2639 億美元，到 2026 年將成長至 4.7689 億美元，到 2032 年將達到 8.5398 億美元，年複合成長率為 10.43%。

主要市場統計數據
基準年 2025 4.2639億美元
預計年份：2026年 4.7689億美元
預測年份 2032 8.5398億美元
複合年成長率 (%) 10.43%

全面介紹寵物基因檢測套組市場的現狀，基因組學、與臨床實踐的結合以及消費者需求都在共同作用，重塑著這個市場。

隨著基因組學與伴侶動物照護的交叉領域不斷拓展，寵物基因檢測套組已從小眾愛好發展成為飼主主人和獸醫專業人士都能用來輔助日常決策的實用工具。檢查室處理能力的提升、樣本處理時間的縮短以及寵物飼主遺傳學知識的普及，共同造就了更廣闊的市場。同時，獸醫專業人士也日益認知到基因資訊作為臨床病史和影像診斷的補充，其價值在於能夠實現早期療育、制定個人化的健康管理方案，並做出更可靠的繁殖決策。

技術成熟、監管清晰以及飼主期望的改變正在推動整個測試組合和分銷模式發生根本性過程。

寵物基因檢測領域正經歷著一場變革，其驅動力包括技術的成熟、消費者期望的不斷變化以及臨床對基因數據的接受度日益提高。高通量定序和先進的PCR技術的應用縮短了檢測結果的返回時間，並拓寬了可檢測突變的範圍，使醫療機構能夠更有信心地提供更豐富的資訊。同時，數位化平台透過將基因型與可操作的表現型描述聯繫起來，增強了結果的可解讀性，將複雜的數據轉化為可執行的護理建議。

該評估旨在評估近期關稅調整對美國檢測套組供應商的籌資策略、供應鏈韌性和營運風險的影響。

美國關稅環境的變化為跨國供應鏈企業帶來了新的挑戰，尤其是那些從海外採購試劑、定序設備或成品檢測套組的企業。關稅調整會影響檢查室耗材和硬體的投入成本，企業在權衡成本、前置作業時間和可靠性之間時，也可能需要調整供應商選擇策略。為此，許多企業正在重新審視其採購體系，並探索近岸外包和其他替代採購方案，以維持利潤率並穩定服務水準。

我們透過實際的細分分析來指導策略性投資決策，該分析整合了寵物種類、測試目的、通路、測試技術和最終用戶需求。

精細的市場區隔分析清楚地展現了科學能力、臨床需求和商業管道之間的交集。基於寵物品種的市場研究著重分析貓狗飼主動態特性和醫療需求的差異。犬類檢測往往側重於品種鑑定和遺傳疾病篩檢，而貓類檢測則更側重於特定疾病標記和性狀分析。基於檢測類型的分析涵蓋了品種鑑定、遺傳疾病篩檢和性狀分析等領域。每種檢測類別都有其自身的檢驗要求、報告標準和臨床應用案例，這些都會影響檢查室的工作流程和消費者資訊的傳播。基於通路的分析揭示了從線上零售、寵物商店到獸醫診所的整個生態系統，並指出了消費者在銷售點教育、退貨政策和檢測後諮詢方面的期望差異。

區域比較分析揭示了美洲、歐洲、中東和非洲以及亞太市場在需求、監管標準和流通結構的差異。

區域特徵對需求推動要素、監管預期和通路結構有顯著影響。在美洲，消費者對寵物保健產品表現出較高的熟悉度，對直接面對消費者（D2C）服務的需求強勁，同時獸醫網路正在加強與診斷服務提供者的合作，並將基因資訊融入日常診療實踐中。該地區還擁有密集的零售生態系統，專注於發展將檢測、遠端醫療和基因諮詢相結合的附加價值服務。

公司如何透過科學嚴謹性、平台柔軟性和策略合作夥伴關係脫穎而出，從而在寵物基因檢測生態系統中建立值得信賴的地位。

寵物基因檢測領域的競爭格局呈現出成熟診斷實驗室、技術驅動新興參與企業和專業細分領域企業之間的平衡。領先的實驗室憑藉其深入的突變分析、認證資格和廣泛的檢驗資料集脫穎而出，並以此為基礎建立起臨床醫生的信任和機構合作關係。科技主導新興參與企業則傾向於提昇平台靈活性、改進使用者介面以及垂直整合數位分析，將原始數據轉化為對飼主和獸醫的實際指南。專業細分領域企業則專注於特定疾病或品種，提供可靠的檢測結果和專業的諮詢服務，從而吸引知識淵博的消費者和繁殖者。

寵物基因檢測市場的領導企業正在採取切實有效的策略措施，以提高臨床可靠性、營運彈性和客戶接受度。

產業領導者應優先採取一系列策略措施，在保持科學可信度的同時加速技術推廣應用。首先，投資於解釋框架和檢驗研究，以證明其在常見遺傳疾病和影響分析中的臨床效用。可靠的證據和同行評審的檢驗能夠加強與獸醫合作夥伴的關係，並減少臨床引入過程中的阻力。其次，透過試劑來源多元化、評估近岸外包機會以及簽訂長期供應商協議來最佳化供應鏈，從而降低關稅波動風險並維持服務水準。第三，設計整合清晰的檢測前教育、針對飼主的具體檢測後指導以及支持循證決策的高效臨床醫生介面的客戶體驗。

調查方法，詳細介紹了多源整合、專家諮詢和檢驗程序，以確保為決策者提供可靠、實用的見解。

本研究整合了已發表的文獻、技術標準、專利趨勢以及對檢查室管理人員、執業獸醫和產品負責人的專家訪談，建構了寵物基因檢測領域的全貌。關鍵資料來源包括深入訪談，探討檢測檢驗方法、報告預期和通路經濟效益；同時輔以一手和二手調查，以了解次世代定序(NGS) 和 PCR 平台的技術能力。調查方法強調證據三角驗證，將來自從業人員的定性見解與對檢測設計和監管指南的技術審查相結合，從而得出平衡的結論。

結論是，綜合證據、健全的營運結構和以用戶為中心的方法將決定寵物基因檢測領域的長期成功。

實驗室技術的進步、報告框架的完善以及飼主參與度的提高，正使寵物基因檢測套組成為個人化寵物照護的策略基礎。這些趨勢為企業創造了機遇，使其能夠拓展臨床效用、實現分銷模式多元化，並透過附加價值服務深化客戶關係。為了抓住這些機遇，相關人員必須優先考慮檢驗、明確溝通管道並建立穩健的供應鏈，同時也需關注區域監管差異和不斷變化的資料管治預期。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：以寵物類型分類的寵物基因檢測套組市場

  • 貓
  • 狗

第9章：寵物基因檢測套組市場（依檢測類型分類）

  • 品種鑑定
  • 遺傳疾病篩檢
  • 特徵分析

第10章：寵物基因檢測套組市場：依分銷管道分類

  • 線上零售
  • 寵物專賣店
  • 動物醫院

第11章 寵物基因檢測套組市場：依技術分類

  • 次世代定序
  • PCR

第12章 寵物基因檢測套組市場：依最終用戶分類

  • 寵物飼主
  • 研究機構
  • 獸醫診斷檢查室

第13章 寵物基因檢測套組市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 寵物基因檢測套組市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 寵物基因檢測套組市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國寵物基因檢測套組市場

第17章：中國寵物基因檢測套組市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AlphaBiolabs Limited
  • Animal Genetics, Inc.
  • Basepaws, Inc.
  • DNA My Dog, LLC
  • Embark Veterinary, Inc.
  • GenSol Diagnostics, LLC
  • Mars, Incorporated
  • Neogen Corporation
  • Orivet Innovations Pty Ltd
  • Paw Print Genetics, LLC
  • PetDx, Inc.
  • Prenetics Global Limited
Product Code: MRR-2B5802CFEA36

The Pet Genetic Test Kits Market was valued at USD 426.39 million in 2025 and is projected to grow to USD 476.89 million in 2026, with a CAGR of 10.43%, reaching USD 853.98 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 426.39 million
Estimated Year [2026] USD 476.89 million
Forecast Year [2032] USD 853.98 million
CAGR (%) 10.43%

A comprehensive primer on how genomics, clinical practice integration, and consumer demand are collectively reshaping the pet genetic test kit landscape

The expanding intersection of genomics and companion animal care has elevated pet genetic test kits from niche curiosities to practical tools that inform day-to-day decisions for owners and practitioners alike. Advances in laboratory throughput, reductions in per-sample processing time, and the mainstreaming of genetic literacy among pet owners have all contributed to a more receptive market. In parallel, veterinary professionals are increasingly recognizing genetic information as complementary to clinical history and diagnostic imaging, enabling earlier intervention, bespoke wellness plans, and more confident breeding decisions.

Moreover, the maturation of direct-to-consumer models has lowered barriers to access while simultaneously raising expectations for clarity, clinical relevance, and data security. This dynamic has driven platform providers to refine reporting, improve variant interpretation frameworks, and strengthen user experience. As technologies evolve, test portfolios continue to broaden, moving beyond single-gene assays to multi-gene panels and more comprehensive trait analyses. Taken together, these shifts position pet genetic test kits as a consequential element of modern pet care, attractive to owners seeking personalized insights and to practitioners who aim to integrate genomic data into evidence-based practice.

How technological maturation, evolving regulatory clarity, and shifting owner expectations are driving decisive transformations across testing portfolios and distribution models

The landscape for pet genetic testing is undergoing transformative shifts driven by technological maturation, evolving consumer expectations, and an expanding clinical acceptance of genetic data. High-throughput sequencing and refined PCR applications have reduced turnaround times and increased the breadth of detectable variants, enabling providers to deliver richer insights with improved confidence. At the same time, digital platforms are enhancing the interpretability of results by linking genotype to actionable phenotype narratives, thereby translating complex data into practical care recommendations.

Concurrently, the regulatory conversation around genetic testing for companion animals is gaining clarity in many jurisdictions, prompting providers to elevate their clinical validation standards and transparency practices. Consumer behavior has shifted toward proactive health management for pets, and this is reflected in growing interest for preventive genetic screens and trait analyses that inform nutrition, exercise, and monitoring strategies. Partnerships across veterinary networks, diagnostic labs, and retail channels are becoming more strategic, enabling broader distribution while preserving clinical integrity. These interlocking developments are creating a market environment in which speed, evidence-backed interpretation, and trustworthiness become decisive competitive differentiators.

Assessing how recent tariff adjustments are reshaping procurement strategies, supply-chain resilience, and operational risk for test kit providers in the United States

The evolving tariff landscape in the United States has introduced additional considerations for companies operating across international supply chains, particularly where reagents, sequencing instruments, or finished testing kits are procured from abroad. Tariff adjustments can influence input costs for lab consumables and hardware, and they may also alter supplier selection strategies as firms assess the trade-offs between cost, lead time, and reliability. In response, many operators reassess procurement footprints, exploring nearshoring and alternative sourcing to preserve margin and maintain consistent service levels.

Beyond procurement, tariffs can incentivize vertical integration strategies where larger providers absorb more elements of production to mitigate exposure to cross-border duties. Smaller laboratories and direct-to-consumer vendors may seek long-term supply contracts or engage in collaborative purchasing arrangements to stabilize prices. Importantly, program managers must also consider the indirect effects of tariffs on partner ecosystems, including distributors and veterinary clinics, since increased costs can cascade through channel economics and reshape pricing structures. Ultimately, tariff volatility underscores the need for dynamic sourcing models, scenario planning, and cost-control measures to ensure resilient operations.

Actionable segmentation insights that align pet type, testing purpose, distribution pathways, laboratory technology, and end-user needs to guide strategic investment decisions

A nuanced view of segmentation provides clarity on where scientific capability, clinical demand, and commercial channels intersect. Based on Pet Type, market study focuses on distinct owner behaviors and medical needs for Cat and Dog populations, with canine testing typically reflecting higher demand for breed identification and inherited condition screening while feline testing emphasizes specific disease markers and trait characterization. Based on Test Type, the landscape spans Breed Identification, Genetic Disease Screening, and Trait Analysis; each test category has unique validation requirements, reporting conventions, and clinical use-cases that influence lab workflows and consumer messaging. Based on Distribution Channel, the ecosystem extends through Online Retail, Pet Specialty Stores, and Veterinary Clinics, creating divergent expectations around point-of-sale education, return policies, and post-test counseling.

Furthermore, Based on Technology, providers adopt either Next Generation Sequencing or PCR platforms; sequencing affords broader variant detection and scalability for panel expansion, whereas PCR delivers rapid, cost-effective assays for targeted markers and high-throughput screening. Based on End User, segmentation differentiates Pet Owners, Research Institutions, and Veterinary Diagnostics Labs, each with distinct requirements for data granularity, reporting formats, and regulatory compliance. Integrating these segmentation lenses reveals clear priority areas for product development, customer experience design, and partnership models, and it also illuminates where technical investment will deliver the greatest incremental value across customer cohorts.

Comparative regional insights that illuminate how demand, regulatory norms, and channel structures differ across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics shape demand drivers, regulatory expectations, and channel structures in meaningful ways. In the Americas, consumers display high familiarity with pet wellness products and a strong appetite for direct-to-consumer offerings, while veterinary networks increasingly partner with diagnostic providers to integrate genetic information into routine care. This region also features dense retail ecosystems and an emphasis on value-added services that bundle testing with telemedicine or genetic counseling.

In Europe, Middle East & Africa, the regulatory environment and clinical practice norms vary substantially across countries, leading companies to adopt differentiated go-to-market strategies; in some markets, stringent regulatory standards and a conservative clinical culture prioritize validated assays and veterinary-mediated distribution, whereas emerging markets within the region present opportunities for education-led adoption and tiered pricing models. Across Asia-Pacific, growth is shaped by rapid digital adoption, expanding pet ownership, and a mix of sophisticated urban markets alongside cost-sensitive segments; providers often navigate complex logistics and localization requirements, including language, reporting templates, and alignment with local veterinary protocols. Recognizing these regional contrasts allows firms to calibrate product portfolios, compliance investments, and channel partnerships to local market expectations while maintaining coherent global standards of quality and interpretation.

How companies are differentiating through scientific rigor, platform agility, and strategic partnerships to establish trusted positions in the pet genetic testing ecosystem

Competitive dynamics in the pet genetic testing space reflect a balance between established diagnostic laboratories, technology-focused entrants, and niche specialists. Leading laboratories differentiate themselves through depth of variant curation, accreditation credentials, and extensive validation datasets, which together underpin clinician trust and institutional partnerships. Technology-driven entrants tend to emphasize platform agility, improved user interfaces, and vertical integration of digital analytics to convert raw data into actionable guidance for owners and practitioners. Niche specialists often focus on a narrow set of conditions or breed groups, offering high-confidence results and domain-specific counseling that appeals to informed consumers and breeders.

Strategic collaborations among companies, veterinary networks, and research centers are common, enabling the sharing of variant evidence and the co-development of validated panels. Companies that prioritize transparent variant interpretation, invest in clinician education, and offer flexible delivery through both retail and clinical channels generally secure stronger adoption. As privacy and data governance become more central to stakeholder expectations, firms that implement rigorous consent frameworks and clear data-use policies gain a reputational advantage. The most resilient competitors combine scientific rigor with accessible reporting and robust channel relationships, positioning themselves to capture both clinical and consumer demand streams.

Practical, high-impact strategic steps for market leaders to enhance clinical credibility, operational resilience, and customer adoption in pet genetic testing

Industry leaders should prioritize a set of strategic moves that accelerate adoption while safeguarding scientific credibility. First, invest in interpretive frameworks and validation studies that demonstrate clinical utility for common inherited conditions and high-impact trait analyses; robust evidence and peer-reviewed validation will strengthen relationships with veterinary partners and reduce friction in clinical adoption. Second, optimize supply chains by diversifying reagent sourcing, evaluating nearshoring opportunities, and establishing long-term supplier agreements to buffer against tariff-related volatility and to sustain service levels. Third, design customer journeys that integrate clear pre-test education, actionable post-test guidance for owners, and streamlined clinician interfaces to support evidence-based decision-making.

Moreover, consider modular product strategies that allow clients to scale from single-marker PCR tests to broader sequencing-based panels as needs evolve, thereby lowering the barrier to entry while preserving upgrade pathways. Strengthen data governance practices by instituting transparent consent mechanisms, privacy-preserving data architectures, and clear policies on secondary research uses, which together build consumer trust and align with emerging regulatory expectations. Finally, pursue selective partnerships with veterinary networks, research institutions, and specialty retailers to extend reach while ensuring consistent messaging and clinical oversight; these relationships can also support longitudinal data collection that enhances variant interpretation over time.

Methodology detailing the multi-source synthesis, expert consultations, and validation steps used to ensure robust, actionable insights for decision-makers

This research synthesizes publicly available literature, technical standards, patent landscapes, and expert interviews with laboratory directors, practicing veterinarians, and product leaders to construct a comprehensive view of the pet genetic testing domain. Primary inputs included in-depth interviews that explored assay validation practices, reporting expectations, and channel economics, complemented by secondary research that mapped technological capabilities across Next Generation Sequencing and PCR platforms. The methodology emphasizes triangulation of evidence, combining qualitative insights from practitioners with technical reviews of assay architectures and regulatory guidance to ensure balanced conclusions.

Analytical steps included cross-segmentation comparisons to identify where technology choice, end-user needs, and distribution channels intersect, followed by scenario planning to assess the operational implications of tariff shifts and supply-chain disruptions. Quality control measures comprised source verification, stakeholder corroboration, and sensitivity checks on key assumptions underlying strategic recommendations. Where gaps in public evidence existed, targeted expert consultations filled information voids, and all interpretive statements were grounded in consensus perspectives or documented technical rationale. Transparency in the research approach enables readers to understand the provenance of insights and to apply them appropriately within their own operational contexts.

Concluding perspectives on how integrated evidence, resilient operations, and user-centric delivery will determine long-term success in the pet genetic testing arena

The convergence of improved laboratory technologies, more sophisticated reporting frameworks, and heightened owner engagement is positioning pet genetic test kits as a strategic enabler of personalized pet care. Together, these trends create opportunities for companies to expand clinical utility, diversify distribution models, and deepen customer relationships through value-added services. To realize these opportunities, stakeholders must prioritize validation, clarity of communication, and resilient supply chains, while remaining attentive to regional regulatory differences and evolving data governance expectations.

As the field matures, the most successful organizations will be those that combine scientific excellence with user-centric design and strong channel partnerships. They will invest in evidence that links genetic findings to actionable care pathways, streamline access through multiple distribution touchpoints, and maintain transparent policies that build trust in long-term data stewardship. Ultimately, genetic testing is most valuable when it complements clinical judgment and empowers owners with information that can meaningfully improve health outcomes and strengthen the human-animal bond.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pet Genetic Test Kits Market, by Pet Type

  • 8.1. Cat
  • 8.2. Dog

9. Pet Genetic Test Kits Market, by Test Type

  • 9.1. Breed Identification
  • 9.2. Genetic Disease Screening
  • 9.3. Trait Analysis

10. Pet Genetic Test Kits Market, by Distribution Channel

  • 10.1. Online Retail
  • 10.2. Pet Specialty Stores
  • 10.3. Veterinary Clinics

11. Pet Genetic Test Kits Market, by Technology

  • 11.1. Next Generation Sequencing
  • 11.2. Pcr

12. Pet Genetic Test Kits Market, by End User

  • 12.1. Pet Owners
  • 12.2. Research Institutions
  • 12.3. Veterinary Diagnostics Labs

13. Pet Genetic Test Kits Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pet Genetic Test Kits Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pet Genetic Test Kits Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pet Genetic Test Kits Market

17. China Pet Genetic Test Kits Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AlphaBiolabs Limited
  • 18.6. Animal Genetics, Inc.
  • 18.7. Basepaws, Inc.
  • 18.8. DNA My Dog, LLC
  • 18.9. Embark Veterinary, Inc.
  • 18.10. GenSol Diagnostics, LLC
  • 18.11. Mars, Incorporated
  • 18.12. Neogen Corporation
  • 18.13. Orivet Innovations Pty Ltd
  • 18.14. Paw Print Genetics, LLC
  • 18.15. PetDx, Inc.
  • 18.16. Prenetics Global Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL PET GENETIC TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PET GENETIC TEST KITS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PET GENETIC TEST KITS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PET GENETIC TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PET GENETIC TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY CAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY CAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY CAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY DOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY DOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY DOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY BREED IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY BREED IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY BREED IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY GENETIC DISEASE SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY GENETIC DISEASE SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY GENETIC DISEASE SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TRAIT ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TRAIT ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TRAIT ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET OWNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET OWNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY VETERINARY DIAGNOSTICS LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY VETERINARY DIAGNOSTICS LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY VETERINARY DIAGNOSTICS LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS PET GENETIC TEST KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA PET GENETIC TEST KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. GCC PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. GCC PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. GCC PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. GCC PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. G7 PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. G7 PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. G7 PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. G7 PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. G7 PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. G7 PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. NATO PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NATO PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. NATO PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NATO PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. NATO PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. NATO PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA PET GENETIC TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)